Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Greenlee

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Pharmaceutical Research|October 1, 1987
Renin inhibitorsW J Greenlee
Medicinal Research Reviews|April 1, 1990
Renin inhibitorsW J Greenlee
Journal of Medicinal Chemistry|January 1, 1989
Synthesis of an analogue of tabtoxinine as a potential inhibitor of D-alanine:D-alanine ligase (ADP forming)W J Greenlee, J P Springer, A A Patchett
The Journal of Biological Chemistry|December 9, 1994
Identification of peptide binding residues in the extracellular domains of the AT1 receptorS A Hjorth, H T Schambye, W J Greenlee, et al.
Journal of Computer-Aided Molecular Design|October 1, 1994
Derivation of a 3D pharmacophore model for the angiotensin-II site one receptorK Prendergast, K Adams, W J Greenlee, et al.
Journal of the American Society of Nephrology : JASN|July 1, 1997
Renal protection by a dual ETA/ETB endothelin antagonist, L-754,142, after aortic cross-clamping in the dogS M Krause, T F Walsh, W J Greenlee, et al.
The Journal of Biological Chemistry|January 27, 1995
Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptorS Perlman, H T Schambye, R A Rivero, et al.
Journal of Medicinal Chemistry|April 1, 1985
Angiotensin-converting enzyme inhibitors: synthesis and biological activity of acyl tripeptide analogues of enalaprilW J Greenlee, P L Allibone, D S Perlow, et al.
Biochemical and Biophysical Research Communications|July 31, 1984
Azapeptides: a new class of angiotensin-converting enzyme inhibitorsW J Greenlee, E D Thorsett, J P Springer, et al.
Journal of Medicinal Chemistry|October 5, 2001
Discovery of 4-[(Z)-(4-bromophenyl)- (ethoxyimino)methyl]-1'-[(2,4-dimethyl-3- pyridinyl)carbonyl]-4'-methyl-1,4'- bipiperidine N-oxide (SCH 351125): an orally bioavailable human CCR5 antagonist for the treatment of HIV infectionA Palani, S Shapiro, J W Clader, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Pharmaceutical Research|October 1, 1987
Renin inhibitorsW J Greenlee
Medicinal Research Reviews|April 1, 1990
Renin inhibitorsW J Greenlee
Journal of Medicinal Chemistry|January 1, 1989
Synthesis of an analogue of tabtoxinine as a potential inhibitor of D-alanine:D-alanine ligase (ADP forming)W J Greenlee, J P Springer, A A Patchett
The Journal of Biological Chemistry|December 9, 1994
Identification of peptide binding residues in the extracellular domains of the AT1 receptorS A Hjorth, H T Schambye, W J Greenlee, et al.
Journal of Computer-Aided Molecular Design|October 1, 1994
Derivation of a 3D pharmacophore model for the angiotensin-II site one receptorK Prendergast, K Adams, W J Greenlee, et al.
Journal of the American Society of Nephrology : JASN|July 1, 1997
Renal protection by a dual ETA/ETB endothelin antagonist, L-754,142, after aortic cross-clamping in the dogS M Krause, T F Walsh, W J Greenlee, et al.
The Journal of Biological Chemistry|January 27, 1995
Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptorS Perlman, H T Schambye, R A Rivero, et al.
Journal of Medicinal Chemistry|April 1, 1985
Angiotensin-converting enzyme inhibitors: synthesis and biological activity of acyl tripeptide analogues of enalaprilW J Greenlee, P L Allibone, D S Perlow, et al.
Biochemical and Biophysical Research Communications|July 31, 1984
Azapeptides: a new class of angiotensin-converting enzyme inhibitorsW J Greenlee, E D Thorsett, J P Springer, et al.
Journal of Medicinal Chemistry|October 5, 2001
Discovery of 4-[(Z)-(4-bromophenyl)- (ethoxyimino)methyl]-1'-[(2,4-dimethyl-3- pyridinyl)carbonyl]-4'-methyl-1,4'- bipiperidine N-oxide (SCH 351125): an orally bioavailable human CCR5 antagonist for the treatment of HIV infectionA Palani, S Shapiro, J W Clader, et al.
Pageof 4